Cargando…
Gut Microbiota in Depression: A Focus on Ketamine
According to the WHO, major depressive disorder is the leading cause of disability worldwide, and it is a major contributor to the overall global burden of disease. The pathophysiology of this common and chronic disease is still not completely understood. The gut microbiome is an increasingly recogn...
Autores principales: | Wilkowska, Alina, Szałach, Łukasz Piotr, Cubała, Wiesław Jerzy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8261217/ https://www.ncbi.nlm.nih.gov/pubmed/34248517 http://dx.doi.org/10.3389/fnbeh.2021.693362 |
Ejemplares similares
-
Ketamine in Bipolar Disorder: A Review
por: Wilkowska, Alina, et al.
Publicado: (2020) -
The Downstaging Concept in Treatment-Resistant Depression: Spotlight on Ketamine
por: Wilkowska, Alina, et al.
Publicado: (2022) -
Affective Switch Associated With Oral, Low Dose Ketamine Treatment in a Patient With Treatment Resistant Bipolar I Depression. Case Report and Literature Review
por: Wilkowska, Alina, et al.
Publicado: (2020) -
Antianhedonic Effect of Repeated Ketamine Infusions in Patients With Treatment Resistant Depression
por: Wilkowska, Alina, et al.
Publicado: (2021) -
Changes in T-Cell Subpopulations and Cytokine Levels in Patients with Treatment-Resistant Depression—A Preliminary Study
por: Szałach, Łukasz Piotr, et al.
Publicado: (2022)